Skip to main content
Caplight Logo









VEROVACCiNES GmbH

VEROVACCiNES GmbH

Private
Halle (Saale)Healthcare & Life Scienceshttps://verovaccines.com/

Last Round

VC Round

Feb 25, 2025

Total Funding Raised

$7.24M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

VEROVACCiNES GmbH is a biopharmaceutical company that develops innovative, yeast-based subunit vaccines for animal health.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

animal healthveterinary vaccinesvaccine platformLactococcus lactisvector technologybiotech R&Danimal biotechveterinary pharmaoral immunizationcold-chain freevaccine licensinganimal health techlivestock healthbiotech licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VEROVACCiNES GmbH Comparables

Compare VEROVACCiNES GmbH with similar companies based on industry and business-model similarity.

VEROVACCiNES GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LivingMed Biotech
85%
The Vaccine Group
84%
ViroVet
83%

VEROVACCiNES GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundFeb 25, 2025
Series BOct 14, 2021
GrantDec 3, 2019
SeedDec 3, 2019
GrantApr 17, 2018
Seed
Dec 1, 2017

Key People

Founding team and executive leadership

Hanjo Hennemann

Co-founder CEO

Founding Team

VEROVACCiNES GmbH Investors

Notable investors and investment history

VEROVACCiNES GmbH investors
InvestorRounds
High-Tech GründerfondsVC Round, Seed
FoundersVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2026

    Open roles increased to 4, 2.3x the trailing average.

  • Feb 25, 2025

    $1.68M round led by High-Tech Gründerfonds.

VEROVACCiNES GmbH Filings

Explore SEC and related filing metadata, where available.

VEROVACCiNES GmbH filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about VEROVACCiNES GmbH's valuation, stock price, and market status.

Is VEROVACCiNES GmbH a public or private company?

VEROVACCiNES GmbH is a private company.

What is the current stock price of VEROVACCiNES GmbH?

VEROVACCiNES GmbH is a private company with no public stock price. No recent secondary market data is available.

How much is VEROVACCiNES GmbH worth (valuation)?

Valuation information for VEROVACCiNES GmbH is not publicly available.

Can I buy VEROVACCiNES GmbH stock?

VEROVACCiNES GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was VEROVACCiNES GmbH's last funding round?

VEROVACCiNES GmbH's most recent funding round was Early Funding on February 25, 2025.

Who are the main investors in VEROVACCiNES GmbH?

Key investors in VEROVACCiNES GmbH include High-Tech Gründerfonds.

Will VEROVACCiNES GmbH IPO soon?

No public IPO plans have been announced for VEROVACCiNES GmbH.

How can I track VEROVACCiNES GmbH secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor VEROVACCiNES GmbH's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHalle (Saale)
Employee Range7
Year Founded2017
Last FundingFeb 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?